You will lead the next new wave intelligence of innovation

Cathy Wood believes the convergence of technologies, especially artificial intelligenceIt creates transformative investment opportunities across multiple sectors despite the current uncertainty in the market.

during Online symposium It was hosted by the investment platform in the UK investment on Thursday, Ark Invest The CEO and chief investment officials explained how artificial intelligence accelerated innovation through health care, independent leadership and software development, while mainly changing economic growth expectations during the next five years.

According to Wood, “Artificial Intelligence is the biggest catalyst for change there,” describing how artificial intelligence will affect all technology and accelerate innovation across sectors.

The investment strategy highlighted how its company analysts organize around these technologies instead of traditional sectors, allowing them to determine opportunities that extend multiple industries.

Artificial intelligence transforms major areas such as independent driving, where Wood is believed Tesla Inc. (Tsla) Robotaxis will reach a decisive intense milestone this year.

“By the end of this year, we believe, thanks to artificial intelligence, that robotics, or at least robotics Tesla, will be safer than a human driver,” Wood stated, noting that Tesla is approaching the safety threshold for one accident per 700,000 miles achieved by human drivers.

This improvement in safety, as well as the organizational changes that Wood expects within the framework of current management, can accelerate the adoption of independent leadership technology and the transfer of transport economics.

“The final price is widely … when expanding the range of a full global robotics network, it will be 25 cents per mile compared to $ 2 to 4 dollars per mile,” Wood explained now.

Amnesty International’s transformational impact on health care was another axis, especially in drug discovery where companies love Recursion Therapeutics Inc. (RXRX) The researcher’s productivity witnessed more than ten times in only one year, according to Lod.

“The number of hypotheses that the researcher can test in Recursion Therapeutics has moved from 20 to 200 a year,” she said, adding that the schedule for the development of medicines may shrink from 13 years to eight years while costs drop from $ 2.4 billion to 600 million dollars per medicine.

Besides market fluctuations in the short term, Wood maintains an optimistic look with a vision of rapid economic growth driven by rapprochement technologies.

“Over the next five years, we expect the growth rate (gross domestic product) to be more than twice, based on the convergence of technologies,” Wood predicted, pointing to the historical precedent of technological inventions that lead to an increase in economic growth.